Call for action to secure universal access to ART in developing countries

The Lancet

Volumn 375, Issue 9727, 2010, Pages 1693-1694

  Orsi, Fabienne ^a   Carrieri, M Patrizia ^a,b   Coriat, Benjamin ^c   Delaporte, Eric ^e,f   Moatti, Jean Paul ^a   Spire, Bruno ^a,d   Taverne, Bernard ^f   Barré Sinoussi, Françoise ^g  

^a AIX MARSEILLE UNIVERSITY   (France)

^b OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d AIDES   (France)

^e UNIV MONTPELLIER   (France)

^f INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^g INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GENERIC DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4+ T LYMPHOCYTE; DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; FUNDING; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PATENT; PRIORITY JOURNAL; SCALE UP; WORLD HEALTH ORGANIZATION;

EID: 77952104186     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60737-4     Document Type: Letter

References (5)

1. Crowley S., Rollins N., Shaffer N., Guerma T., Vitoria M., and Lo Y.R. New WHO HIV treatment and prevention guidelines. Lancet 375 (2010) 874-875
2. WHO. Transactional prices for antiretroviral medicines and HIV diagnostics from 2008 to October 2009. http://www.who.int/hiv/amds/GPRMsummaryReportNov2009.pdf (accessed December, 2009).
3. Orsi F., D'Almeida C., Hasenclever L., Camara M., Tigre P., and Coriat B. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges. Aids 21 (2007) 1997-2003
4. In: Coriat B. (Ed). The political economy of HIV/AIDS in developing countries-TRIPS, public health systems and free access (2008), Edward Elgard Editions, Cheltenham
5. Smith R.D., Correa C., and Oh C. Trade, TRIPS, and pharmaceuticals. Lancet 373 (2009) 684-691